IFLR1000

Hyloris Pharmaceuticals Euronext Brussels IPO

17/6/2020
IPO
Select tab

€ 61.8 million

$ 70.5 million

Completed

17/6/2020

Overview:

  • Hyloris Pharmaceuticals, a Belgian biotech company, issued an initial public offering of 5.75 million new shares on Euronext Brussels, raising €61.8 million.
  • The shares were priced at €10.75 each.
  • The proceeds will be used to finance and expand existing pharma product candidates, set up an IV Cardiovascular portfolio team and for other general corporate purposes.

Natasha Forrest - Researcher

Jurisdiction:

Belgium

Deal type:

IPO

Practice area:

Capital markets : Equity

Industry sector:

Pharmaceuticals and life sciences

Firms:
Eubelius

Party: Hyloris Pharmaceuticals (Issuer)

Lawyers: Erwin Destuyver, Lars Van Bever

Linklaters

Party: KBC Securities (Underwriter)

Party: Van Lanschot Kempen Wealth Management (Underwriter)

Related deals